Genome-wide interaction of genotype by erythrocyte n-3 fatty acids contributes to phenotypic variance of diabetes-related traits

Ju-Sheng Zheng,Chao-Qiang Lai,Laurence D Parnell,Yu-Chi Lee,Jian Shen,Caren E Smith,Patricia Casas-Agustench,Kris Richardson,Duo Li,Sabrina E Noel,Katherine L Tucker,Donna K Arnett,Ingrid B Borecki,José M Ordovás
DOI: https://doi.org/10.1186/1471-2164-15-781
IF: 4.547
2014-01-01
BMC Genomics
Abstract:Background Little is known about the interplay between n-3 fatty acids and genetic variants for diabetes-related traits at the genome-wide level. The present study aimed to examine variance contributions of genotype by environment (GxE) interactions for different erythrocyte n-3 fatty acids and genetic variants for diabetes-related traits at the genome-wide level in a non-Hispanic white population living in the U.S.A. (n = 820). A tool for Genome-wide Complex Trait Analysis (GCTA) was used to estimate the genome-wide GxE variance contribution of four diabetes-related traits: HOMA-Insulin Resistance (HOMA-IR), fasting plasma insulin, glucose and adiponectin. A GxE genome-wide association study (GWAS) was conducted to further elucidate the GCTA results. Replication was conducted in the participants of the Boston Puerto Rican Health Study (BPRHS) without diabetes (n = 716). Results In GOLDN, docosapentaenoic acid (DPA) contributed the most significant GxE variance to the total phenotypic variance of both HOMA-IR (26.5%, P -nominal = 0.034) and fasting insulin (24.3%, P -nominal = 0.042). The ratio of arachidonic acid to eicosapentaenoic acid + docosahexaenoic acid contributed the most significant GxE variance to the total variance of fasting glucose (27.0%, P -nominal = 0.023). GxE variance of the arachidonic acid/eicosapentaenoic acid ratio showed a marginally significant contribution to the adiponectin variance (16.0%, P -nominal = 0.058). None of the GCTA results were significant after Bonferroni correction ( P < 0.001). For each trait, the GxE GWAS identified a far larger number of significant single-nucleotide polymorphisms ( P -interaction ≤ 10E-5) for the significant E factor (significant GxE variance contributor) than a control E factor (non-significant GxE variance contributor). In the BPRHS, DPA contributed a marginally significant GxE variance to the phenotypic variance of HOMA-IR (12.9%, P -nominal = 0.068) and fasting insulin (18.0%, P -nominal = 0.033). Conclusion Erythrocyte n-3 fatty acids contributed a significant GxE variance to diabetes-related traits at the genome-wide level.
What problem does this paper attempt to address?